Filing Flows › Apyx Medical (APYX) › Who owns the stock
Who owns Apyx Medical (APYX) stock
62 funds reported Apyx Medical (APYX) shares in their latest 13F filings, worth $106M in all. The largest holder is Nantahala Capital Management, LLC ($29.4M). Last quarter 30 funds added to their stakes and 32 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6,540,496 | $29.4M | increase | 2026-06-30 |
| Royce & Associates LP | 3,274,064 | $14.7M | increase | 2026-06-30 |
| Archon Capital Management LLC | 2,644,717 | $11.9M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 1,534,847 | $6.9M | decrease | 2026-06-30 |
| Vanguard Group | 1,565,078 | $5.5M | increase | 2025-12-31 |
| Commonwealth Equity Services, LLC | 649,061 | $2.9M | unchanged | 2026-06-30 |
| Aigh Capital Management LLC | 1,128,343 | $2.8M | unchanged | 2026-09-30 |
| Essex Investment Management Co LLC | 1,101,878 | $2.7M | decrease | 2026-09-30 |
| Horizon Kinetics Asset Management LLC | 585,000 | $2.6M | decrease | 2026-06-30 |
| BlackRock | 560,986 | $2.5M | increase | 2026-06-30 |
| Silverberg Bernstein Capital Management LLC | 1,022,239 | $2.5M | decrease | 2026-09-30 |
| Renaissance Technologies LLC | 554,278 | $2.5M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 400,600 | $1.8M | increase | 2026-06-30 |
| Legato Capital Management LLC | 382,762 | $1.7M | increase | 2026-06-30 |
| SEI Investments | 281,029 | $1.3M | decrease | 2026-06-30 |
Apyx Medical's latest quarter
Apyx Medical, Q3 2026: revenue $14.0M (+9% year over year), operating margin -4.1%, net loss $1.8M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most APYX stock?
By the latest 13F filings: Nantahala Capital Management, LLC ($29.4M); Royce & Associates LP ($14.7M); Archon Capital Management LLC ($11.9M); Vanguard Capital Management LLC ($6.9M); Vanguard Group ($5.5M).
What is the short interest in APYX?
213,730 shares were sold short at the 2026-10-15 settlement, 3.34% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.